DT-109

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameDT-109
Drug Alias NameDT-109
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes MellitusArteriosclerosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDiapin Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesDiapin Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusArteriosclerosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A